Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane and Avastin in Metastatic Melanoma
NCT00462423Phase 2Completed
- Start
- Apr 2007
- Primary completion
- Apr 2011
- Modality
- Polymer-based Nanoparticles, Monoclonal Antibodies, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nab-paclitaxel and bevacizumab in melanoma. Primary endpoint: Progression-free Survival at 4 Months. Started Apr 2007; status: completed.
02
Drugs
nab-paclitaxelbevacizumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00462423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00462423.